Falls are the leading cause of preventable injury, and while many strategies have been developed to try to stop them and their resultant injuries, they remain a persistent problem. Research by Brigham and Women's Hospital ...
Nov 17, 2020
0
4
In the United States, there are persistent racial disparities in asthma prevalence, morbidity and mortality. These disparities can largely be explained by looking at socioeconomic and environmental factors, such as access ...
Jan 11, 2019
0
1
The New England Journal of Medicine reports results of a 2,259-person study conducted at 11 academic medical centers showing that dietary supplementation with vitamin D and/or calcium after removal of pre-cancerous colorectal ...
Oct 14, 2015
0
85
(HealthDay)—For patients with recurrent Clostridium difficile infection (CDI), donor fecal microbiota transplantation (FMT) is safe and more efficacious than autologous FMT, according to a study published online Aug. 23 ...
Aug 24, 2016
0
1
Hospitals face penalties for readmitting recently discharged Medicare patients, but in 27 percent of cases readmissions could be prevented, according to a UCSF-led study of 12 academic medical centers nationwide.
Mar 8, 2016
0
0
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they've been in about a minute, and direct those deemed at risk to the ...
Mar 5, 2020
0
34
(HealthDay)—Four U.S. government-funded clinical trials will search for new therapies for Alzheimer's disease.
Jan 14, 2013
0
0
Cesarean delivery is the most common inpatient surgical procedure in the United States, with 1.4 million c-sections performed each year. Opioids, most commonly oxycodone, are the standard pain medications prescribed to women ...
Jun 8, 2017
0
8
UC Davis Health is recruiting people for a clinical trial with the goal of building a "neurological prosthesis" for restoring speech to people who have lost—or are losing—the ability to speak. The research is aimed at ...
Aug 22, 2022
1
27
Many patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...
Feb 24, 2020
0
2
